Skip to content
  • 6,809 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started

Special notice

Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)

ARPA-H-SN-25-131

National Institutes of Health, Advanced Research Projects Agency for Health (Arpa-H). Research and Development in Biotechnology (except Nanobiotechnology).

Response deadline

October 2, 2025 at 8:59 AM EDT

Closed 395 days ago. Posted October 1, 2025, first published September 25, 2025. Scheduled to archive October 17, 2025.

Get the next one like this from National Institutes of Health by email, the day it is posted.Find my opportunities

This one closed in 2025

18 like it are open now in research and development in biotechnology (except nanobiotechnology)

All 18 open in research and development in biotechnology (except nanobiotechnology)

Description

As published on SAM.gov.

The purpose of this amendment is to:

1. Extend the registration deadline for lightning talks and sidebars to October 2, 2025 at 08:59AM ET.

2. Extend the available days/hours for lightning talks and sidebars. Lightning talks and sidebars slots will now be available on October 3. 2025. Slots for the October 3rd lightning talks and sidebars will be available between 11:00AM ET to 2:00PM ET. In addition, slots for the October 2nd sidebars will now be available between 11:00AM ET and 7:00PM ET.

Please see the revised Special Notice document for additional details.

------------------------------------------------------------------------------------------------------------

This Special Notice (SN) is intended to alert the scientific community to a newly approved ARPA-H Program and notify potential proposers of an associated Proposers’ Day (PD). Under the cognizance of HSF, ARPA-H is publishing an Innovative Solutions Opening (ISO) for the Treating Hereditary Rare diseases with In Vivo precision genetic mEdicines (THRIVE) program no later than September 25, 2025, please monitor SAM.gov for updates (ARPA-H-SOL-25-122).

For additional PD details and registration information see the attached special notice (ARPA-H-SN-25-131).

For more information about the THRIVE program visit: https://arpa-h.gov/explore-funding/programs/thrive

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 25, 2025

    Special notice

    Due September 30, 2025 at 11:59 PM EDT. SAM.gov, notice 158c111f6a0d4952b97419c6dccc068c

    3 revisions on SAM
    • October 1, 2025: publish, special notice
    • September 25, 2025: publish, solicitation
    • September 25, 2025: publish, special notice
  2. October 1, 2025

    Special notice

    Due October 2, 2025 at 8:59 AM EDT. SAM.gov, notice 6b7827d3aa4a4a998fe255808dbb8b86

    2 revisions on SAM
    • October 1, 2025: publish, special notice
    • September 25, 2025: publish, special notice

Points of contact